Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D005342:Fibrinolysis; D006801:Humans; D002532:Intracranial Aneurysm / Q000150:complications*; D012422:Rupture, Spontaneous; D013345:Subarachnoid Hemorrhage / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D014148:Tranexamic Acid / Q000627:therapeutic use*
D003509:Cyclohexanecarboxylic Acids; D014148:Tranexamic Acid